Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies

Therapeutic antibody IgG1 has two N-linked oligosaccharide chains bound to the Fc region. The oligosaccharides are of the complex biantennary type, composed of a trimannosyl core structure with the presence or absence of core fucose, bisecting N-acetylglucosamine (GlcNAc), galactose, and terminal sialic acid, which gives rise to structural heterogeneity. Both human serum IgG and therapeutic antibodies are well known to be heavily fucosylated. Recently, antibody-dependent cellular cytotoxicity (ADCC), a lytic attack on antibody-targeted cells, has been found to be one of the critical effector functions responsible for the clinical efficacy of therapeutic antibodies such as anti-CD20 IgG1 rituximab (Rituxan^®) and anti-Her2/neu IgG1 trastuzumab (Herceptin^®). ADCC is triggered upon the binding of lymphocyte receptors (FcγRs) to the antibody Fc region. The activity is dependent on the amount of fucose attached to the innermost GlcNAc of N-linked Fc oligosaccharide via an α-1,6-linkage, and is dramatically enhanced by a reduction in fucose. Non-fucosylated therapeutic antibodies show more potent efficacy than their fucosylated counterparts both in vitro and in vivo, and are not likely to be immunogenic because their carbohydrate structures are a normal component of natural human serum IgG. Thus, the application of non-fucosylated antibodies is expected to be a powerful and elegant approach to the design of the next generation therapeutic antibodies with improved efficacy. In this review, we discuss the importance of the oligosaccharides attached to the Fc region of therapeutic antibodies, especially regarding the inhibitory effect of fucosylated therapeutic antibodies on the efficacy of non-fucosylated counterparts in one medical agent. The impact of completely non-fucosylated therapeutic antibodies on therapeutic fields will be also discussed.     

采前壳寡糖处理对杏果实黑斑病的抗性诱导

以新疆赛买提杏为试验材料,分别在果实坐果期、膨大期、转色期及采收前48h,采用分子量为5 000、浓度为0.05%的壳寡糖(GOS)溶液对杏果实进行喷施处理,以喷施清水为对照(CK);采收后的杏果实在机械损伤接种链格孢菌后置于4℃、相对湿度90%~95%的条件下贮藏,定期统计接种链格孢菌杏果实的病斑直径和发病率,测定抗病相关酶苯丙氨酸解氨酶(PAL)、β-1,3-葡聚糖酶(GLU)和几丁质酶(CHT)的活性及木质素、富含羟脯氨酸糖蛋白(HRGP)的含量,探讨采前壳寡糖处理对杏果实黑斑病的抗性诱导及其生理机制。结果显示,贮藏结束时,采前壳寡糖处理的果实发病率与病斑直径分别比对照显著降低了16.37%和17.57%。随着贮藏期间的延长,壳寡糖处理杏果实PAL、GLU、CHT的活性和木质素、HRGP的含量均表现出先上升后下降的变化趋势,且始终显著高于同期对照,并分别在接种后第21、28、21、28和14天达到峰值,峰值比同期对照分别显著提高12.17%、78.22%、31.41%、34.81%和77.44%。研究表明,采前壳寡糖处理能通过诱导提高杏果实病程相关蛋白及细胞壁HRGP和木质素的含量来增强杏果实对黑斑病的抗性。     

绿色木霉粗纤维素酶液水解壳聚糖的研究

利用自制绿色木霉粗纤维素酶液降解壳聚糖制备低聚壳聚糖.采用粘度法、乙酰丙酮法和还原糖浓度分析,研究了温度、pH值及反应时间等因素对壳聚糖水解程度和产物相对分子质量的影响,并采用质谱法对水解产物进行定性分析.结果表明,粗纤维素酶液水解壳聚糖作用的最适pH为5.0、最适反应温度为50 ℃、最适反应时间为12 h.粗纤维素酶...     

N-酰化低聚壳聚糖衍生物还原能力的研究

对低聚壳聚糖进行N-酰化改性,制得取代度相同的N-马来酰低聚壳聚糖(NMCOS),N-琥珀酰低聚壳聚糖(NSCOS),N-邻苯二甲酰低聚壳聚糖(NPCOS),其中NMCOS1、NSCOS1、NPCOS1的取代度均为0.25;NMCOS2、NSCOS2、NPCOS2的取代度均为0.49。考察了6种N-酰化低聚壳聚糖衍生物的还原能力。结果表明:当取代度相同时,N-邻苯二甲酰低聚壳聚糖的还原能力最强,其次是N-马来酰低聚壳聚糖,N-琥珀酰低聚壳聚糖的还原能力最差。这可能是由取代基的性质不同所致。     

Nature reserve group planning for conservation of giant pandas in North Minshan, China

Formation of nature reserve groups (NRGs) is an important approach for optimising spatial patterns in nature reserves and for improving the efficiency of nature reserve networks. In this study, based on habitat evaluation and connectivity analysis, the approach and method for optimising spatial patterns and functional zoning of reserves were analysed using the case study of giant panda (Ailuropoda melanoleuca) reserves in North Minshan. Results indicated that five panda nature reserves had been established, which formed a reserve group and covered 48.4% of panda habitat and three of five population components. Although the nature reserves were connected to each other, core zones were divided into seven isolated areas. These divisions can reduce the efficiency of protecting giant pandas in reserve systems. To optimise spatial patterns in nature reserves, one new reserve is proposed and it is recommended that core zones be expanded and merged into two areas, in accordance with the spatial distribution of the panda population. Three linkage areas are also proposed—for facilitating panda exchange and movement among different populations. The study is expected to provide a scientific basis for planning the development of nature reserves in this mountain range, to promote the establishment of nature reserve groups in other areas, and to optimise entire nature reserve systems in China.     

Differential analysis of site-specific glycans on plasma and cellular fibronectins: application of a hydrophilic affinity method for glycopeptide enrichment

Isolation of glycopeptides utilizing hydrogen bonding between glycopeptide glycans and a carbohydrate-gel matrix in the organic phase is useful for site-specific characterization of oligosaccharides of glycoproteins, when combined with mass spectrometry. In this study, recovery of glycopeptides was improved by including divalent cations or increasing the organic solvent in the binding solution, without losing specificity, whereas it was still less effective for those with a long peptide backbone exceeding 50 amino acid residues. The method was then applied to the analysis of glycan heterogeneities at seven N-glycosylation sites in each of the plasma and cellular fibronectins (FNs). There was a remarkable site-specific difference in fucosylation between these isoforms; Asn1244 selectively escaped the global fucosylation of cellular FN, whereas only Asn1007 and Asn2108 of the plasma isoform underwent modification. In addition, a new O-glycosylation site was identified at Thr279 in the connecting segment between the fibrin- and heparin-binding domain and the collagen-binding domain, and the glycopeptide was reactive to a peanut agglutinin lectin. Considering that another mucin-type O-glycosylation site lies within a different connecting segment, the O-glycosylation of FN was suggested to play a significant role in segregating the neighboring domains and thus maintaining the topology of FN and the domain functions. In addition, the method was applied to apolipoprotein B-100 (apoB100) whose N-glycan structures at 17 of 19 potential sites have been reported, and characterized the remaining sites. The results also demonstrated that the enriched glycopeptide provides resources for site-specific analysis of oligosaccharides in glycoproteomics.     

ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter

The angiogenic molecule, vascular endothelial growth factor (VEGF), is a critical regulator of normal and pathologic angiogenesis. ErbB2, an epidermal growth factor receptor family member whose overexpression in mammary tumors is correlated with poor patient prognosis, has been implicated as a positive modulator of VEGF expression. Mammary tumor cells overexpressing ErbB2 (NAFA cells) and a normal mouse mammary cell line (HC11) transfected with ErbB2 expression vectors were used to study the effects of ErbB2 overexpression on VEGF regulation. We found that ErbB2 overexpression led to an increase in endogenous VEGF mRNA as well as ErbB3 protein levels in HC11 cells. Additionally, we determined that ErbB2 overexpression-mediated upregulation of VEGF involves at least two distinct promoter elements, one previously identified as the hypoxia responsive element and the other the core promoter region (-161 to -51bp), which is specifically controlled via two adjacent SP1 binding sites (-80 to -60bp).     

HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients

Understanding the mechanism of hepatitis C virus (HCV) pathogenesis is an important part of HCV research. Recent experimental evidence suggests that the HCV core protein (HCcAg) has numerous functional activities. These properties suggest that HCcAg, in concert with cellular factors, may contribute to pathogenesis during persistent HCV infection. HCV is capable of infecting cells other than hepatocytes. Although the extrahepatic cellular tropism of HCV may play a role in the pathophysiology of this infection, the precise biological significance of the presence of HCV components in different liver cell types presently remains to be established. In this study, HCcAg was detected in nonparenchymal liver cells of six patients out of eight positive for serum HCV RNA. Immunostaining with anti-HCcAg mAbs revealed the presence of this protein in different liver cell types such as lymphocytes, Kupffer, polymorphonuclear, pit, endothelial, stellate, and fibroblast-like cells. Interestingly, HCcAg was immunolabeled not only in the cytoplasm but also in the nucleus of these cells. Remarkably, HCcAg co-localized with large lipid droplets present in stellate cells and with collagen fibers in the extracellular matrix. Moreover, HCcAg was immunolabeled in bile canaliculus suggesting the involvement of the biliary system in the pathobiology of HCV. Data suggest that nonparenchymal liver cells may constitute a reservoir for HCV replication. Besides, HCcAg may contribute to modulate immune function and fibrosis in the liver as well as steatosis.